Intellectual Property
 TRIPS/Doha
a) Official Documents
WTO Declaration on the TRIPS Agreement and Public Health
World Trade Organizaton Ministerial Conference
• Doha, 14 November 2001
Concept Paper for Approaches Relating to Para. 6 of the Doha Declaration on the TRIPS Agreement and Public Health
Draft Communication from the European Coummunities and their Member States to the TRIPS Council.
• 1 February 2002
Implementation of para. 6 of the Doha Declaration on the TRIPS Agreement and Public Health
TRIPS: COUNCIL FOR TRIPS - WT/L/540
• Decision of 30 August 2003
Authorisation of Generic Medicines at WTO level
European Parliament resolution on authorisation of generic medicines at
WTO level — P5_TA(2003)0052.
• 4 February 2004
b) EGA Position Papers
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION
AND INTELLECTUAL PROPERTY
EGA comments to A/PHI/IGWG/2/Conf Paper No 1 - Rev 1
Draft Global Strategy and Plan of Action
• March 2008
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION
AND INTELLECTUAL PROPERTY
EGA Submission to Section 1 of the Draft Global Strategy and Plan of Action
• 1 October 2007
TRIPS and Access to Medicines
EGA Testimony before the European Parliament
• 5 June 2007
EGA Position on the Draft Regulation on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems
EGA Position Paper
• March 2005
Outcome of the WTO Ministerial Conference, Doha, November 2001 Declaration on the TRIPS agreement and Public Health
EGA Position Paper
• February 2002
Outcome of the WTO Ministerial Conference, Doha, November 2001 Declaration on the TRIPS agreement and Public Health
EGA Position Paper
• 20 December 2001
TRIPS Article 34 and 50 do not require Automatic Interlocutory Injunctions
EGA Position Paper
• February 2001
TRIPS Article 39.3 Does not require Data Exclusivity Provisions: A critical issue for access to medicines
EGA Position Paper
• July 2000
|
